✦ LIBER ✦

The induction of specific antitumor immunity by in vivo treatment with interleukin-1 and sonicated tumor extract in a murine model

✍ Scribed by Takehisa Harada; Norimichi Kan; Takashi Okino; You Ichinose; Yoshio Moriguchi; LI Li; Tomoharu Sugie; Kazuhisa Ohgaki; Masayuki Imamura

Book ID: 112645359
Publisher: Springer
Year: 1994
Tongue: English
Weight: 273 KB
Volume: 24
Category: Article
ISSN: 1436-2813
DOI: 10.1007/bf01884580

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A new model of active specific immunothe

A new model of active specific immunotherapy using interleukin-1 and sonicated tumor supernatant in murine tumor system

✍ Moriguchi, Yoshio; Kan, Norimichi; Okino, Takashi; Harada, Takehisa; Yamasaki, S 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 716 KB

The possibility of active specific immunotherapy using interleukin-1 (IL-1) plus sonicated tumor supernatant (SS) was examined in a murine tumor model. The growth of intraperitoneally or subcutaneously inoculated plasmacytoma MOPC IME, which is syngeneic to BALB/c mice, was significantly suppressed

Induction of liver fibrosis in a murine

Induction of liver fibrosis in a murine hepatoma model by thioacetamide is associated with enhanced tumor growth and suppressed antitumor immunity

✍ Chang, Chih-Peng; Lei, Huan-Yao; Yang, Ming-Chen 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 917 KB

IRF-1 suppresses tumor formation and pro

IRF-1 suppresses tumor formation and protects against tumor rechallenge in a murine model of breast carcinoma: The role of tumor specific immunity

✍ M.T. Stang; M. Armstrong; Y. Liu; P. Yan; J.H. Yim 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 154 KB

Stimulation of tumor necrosis factor-α,

Stimulation of tumor necrosis factor-α, interleukin-1 and interleukin-6 by a galactoside-specific lectin given in clinically applied mistletoe extract induces antitumor activity in patients

✍ Hajto, Tibor; Hostanska, Katarina 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 183 KB

Induction of effective antitumor immunit

Induction of effective antitumor immunity in a mouse brain tumor model using B7-1 (CD80) and intercellular adhesive molecule 1 (ICAM-1; CD54) transfection and recombinant interleukin 12

✍ Tatsuhiro Joki; Tetsuro Kikuchi; Yasuharu Akasaki; Saburo Saitoh; Toshiaki Abe; 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 139 KB 👁 2 views

Although tumor-specific T lymphocytes recognize tumorassociated antigens (TAA) present on their cell surface via major histocompatibility complex (MHC) molecules, T cells require other activating signals. These are provided by costimulatory molecules, including B7-1 (CD80), B7-2 (CD86) and intercell

In vivo anti-tumor activity of combinati

In vivo anti-tumor activity of combinations of interferon alpha and interleukin-2 in a murine model. Correlation of efficacy with the induction of cytotoxic cells resembling natural killer cells

✍ Michael J. Brunda; Donna Bellantoni; Viveca Sulich 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 French ⚖ 684 KB

The in vivo anti-tumor activity of 2 recombinant cytokines, interleukin-2 (rlL-2) and human hybrid interferon alpha (rHulFN-aA/D), were tested using the murine reticulum cell sarcoma M5076. Experimental hepatic metastases, following i.v. injection of tumor cells, and tumor growth and spontaneous met